Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: a population-based time-series analysis

Original research
par
Kitchen, Sophie A. et al

Date de publication

2022

Géographie

Canada

Langue de la ressource

English

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

Investigated the impact of the expansion in eligibility for take-home doses on trends in the distribution of take-home doses of OAT during COVID-19.

Constatations/points à retenir

The new guidance for dispensing OAT in Ontario resulted in increases in the duration of take-home doses of methadone and buprenorphine/naloxone supplied. However, given that changes were small, strategies to improve retention in OAT and ensure equitable access to take-home dosing should continue.

La conception ou méthodologie de recherche

Population-based time series analysis (June 2019-November 2020)

Mots clés

Substitution/OAT
Policy/Regulatory
Overdose
Evidence base
Carries/take-home doses